Alveolar Cell Cancer

Alveolar cell carcinoma (or synonyms: pulmonary adenomatosis, alveolar cell tumor, cystopapillary lung tumor, bronchioloalveolar) is a rare type of lung cancer that begins in the terminal bronchioles and alveoli. This type of lung cancer is usually diagnosed in young women who do not smoke, but can occur in other groups of the population.

Symptoms of alveolar cell carcinoma may include cough, difficulty breathing, weakness, fatigue, weight loss and decreased appetite. However, these symptoms may not be very obvious, especially in the early stages of the disease.

Diagnosing alveolar cell carcinoma may require various tests, such as bronchoscopy, computed tomography (CT), and biopsy. After diagnosis, doctors determine the degree of development of the disease and choose the most appropriate treatment method.

Treatment for alveolar cell carcinoma may include surgical removal of the tumor, chemotherapy, and radiation therapy. The survival prognosis depends on many factors, such as the stage of the disease, the patient's age and general health.

Overall, alveolar cell carcinoma is a rare type of lung cancer that can be difficult to diagnose and treat. However, modern diagnostic and treatment methods are helping to improve the survival prognosis of patients with this disease. If you experience any symptoms associated with lung disease, consult your doctor for advice and diagnosis. Seeking help early can save lives.

How and why alveolar cell type cancer develops Alveolar cell type cancer (ACC) is a malignant tumor arising from the cells of the alveoli of the lungs. It is a rare but very dangerous type of lung cancer. OAC can develop as a result of mutations in genes responsible for the growth and development of lung cells. Such mutations are usually random and occur due to damage to the cells' DNA, such as from exposure to radiation or chemicals. - CBC occurs as a result of mutated cells that become cancerous and begin to grow and multiply, forming a mass and